Cardiovascular Impact of Calcium and Vitamin D Supplements: A Narrative Review

Overview

Journal Endocrinol Metab (Seoul)

Specialty Endocrinology

Date 2023 Feb 15

PMID 36792577

Authors

Fatima Zarzour

Ahmad Didi

Mohammed Almohaya

David Kendler

Affiliations

Soon will be listed here.

Abstract

Calcium and vitamin D play an important role in mineral homeostasis and the maintenance of skeletal health. Calcium and vitamin D supplements have been widely used for fracture prevention in elderly populations. Many trials have studied the effectiveness and cardiovascular safety of calcium and vitamin D supplementation, with disparate results. In this review, we summarize the most important trials and systematic reviews. There is significant heterogeneity in clinical trial design, differences in the nature of trial outcomes (self-reported vs. verified), prior calcium intake, and trial size. Inconsistent results have been reported concerning the effects of calcium and vitamin D supplementation on cardiovascular outcomes. Most current guidelines recommend calcium intake of up to 1,200 mg daily, preferably from the diet, without concern for cardiovascular risk. Recommendations regarding vitamin D supplementation vary widely. There is compelling evidence from well-conducted randomized trials that modest vitamin D supplementation is safe but does not confer cardiovascular benefit or cardiovascular harm.

Citing Articles

Calcium deficiency and its implications for cardiovascular disease and cancer: Strategies for resolution via agronomic fortification.

Cheng L, Lian J, Ding Y, Wang X, Munir M, Ullah S Food Sci Nutr. 2024; 12(11):8594-8607.

PMID: 39619946 PMC: 11606831. DOI: 10.1002/fsn3.4464.

Association between Daily Dietary Calcium Intake and the Risk of Cardiovascular Disease (CVD) in Postmenopausal Korean Women.

Lee J, Tran T, Choi E, Baek J, Kim H, Kim H Nutrients. 2024; 16(7).

PMID: 38613076 PMC: 11013752. DOI: 10.3390/nu16071043.

Evaluating adherence, tolerability and safety of oral calcium citrate in elderly osteopenic subjects: a real-life non-interventional, prospective, multicenter study.

Rondanelli M, Minisola S, Barale M, Barbaro D, Mansueto F, Battaglia S Aging Clin Exp Res. 2024; 36(1):38.

PMID: 38345765 PMC: 10861607. DOI: 10.1007/s40520-024-02696-9.

Effect of Denosumab on Bone Density in Postmenopausal Osteoporosis: A Comparison with and without Calcium Supplementation in Patients on Standard Diets in Korea.

Jeong C, Kim J, Lee J, Lim Y, Lim D, Baek K J Clin Med. 2023; 12(21).

PMID: 37959369 PMC: 10649665. DOI: 10.3390/jcm12216904.

References

Lappe J, Watson P, Travers-Gustafson D, Recker R, Garland C, Gorham E . Effect of Vitamin D and Calcium Supplementation on Cancer Incidence in Older Women: A Randomized Clinical Trial. JAMA. 2017; 317(12):1234-1243. DOI: 10.1001/jama.2017.2115. View

Reid I, Mason B, Horne A, Ames R, Clearwater J, Bava U . Effects of calcium supplementation on serum lipid concentrations in normal older women: a randomized controlled trial. Am J Med. 2002; 112(5):343-7. DOI: 10.1016/s0002-9343(01)01138-x. View

Eastell R, Rosen C, Black D, Cheung A, Murad M, Shoback D . Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society* Clinical Practice Guideline. J Clin Endocrinol Metab. 2019; 104(5):1595-1622. DOI: 10.1210/jc.2019-00221. View

Schneider A, Lutsey P, Selvin E, Mosley T, Sharrett A, Carson K . Vitamin D, vitamin D binding protein gene polymorphisms, race and risk of incident stroke: the Atherosclerosis Risk in Communities (ARIC) study. Eur J Neurol. 2015; 22(8):1220-7. PMC: 4496275. DOI: 10.1111/ene.12731. View

Larsson S, Burgess S, Michaelsson K . Association of Genetic Variants Related to Serum Calcium Levels With Coronary Artery Disease and Myocardial Infarction. JAMA. 2017; 318(4):371-380. PMC: 5817597. DOI: 10.1001/jama.2017.8981. View

Prince R, Austin N, Devine A, Dick I, Bruce D, Zhu K . Effects of ergocalciferol added to calcium on the risk of falls in elderly high-risk women. Arch Intern Med. 2008; 168(1):103-8. DOI: 10.1001/archinternmed.2007.31. View

Giovannucci E, Liu Y, Hollis B, Rimm E . 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med. 2008; 168(11):1174-80. PMC: 3719391. DOI: 10.1001/archinte.168.11.1174. View

Larsson S, Virtamo J, Wolk A . Potassium, calcium, and magnesium intakes and risk of stroke in women. Am J Epidemiol. 2011; 174(1):35-43. DOI: 10.1093/aje/kwr051. View

Neer R, Arnaud C, Zanchetta J, Prince R, Gaich G, Reginster J . Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med. 2001; 344(19):1434-41. DOI: 10.1056/NEJM200105103441904. View

10.

Giustina A, Bouillon R, Binkley N, Sempos C, Adler R, Bollerslev J . Controversies in Vitamin D: A Statement From the Third International Conference. JBMR Plus. 2020; 4(12):e10417. PMC: 7745884. DOI: 10.1002/jbm4.10417. View

11.

Yang B, Campbell P, Gapstur S, Jacobs E, Bostick R, Fedirko V . Calcium intake and mortality from all causes, cancer, and cardiovascular disease: the Cancer Prevention Study II Nutrition Cohort. Am J Clin Nutr. 2016; 103(3):886-94. DOI: 10.3945/ajcn.115.117994. View

12.

Camacho P, Petak S, Binkley N, Diab D, Eldeiry L, Farooki A . AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS-2020 UPDATE. Endocr Pract. 2020; 26(Suppl 1):1-46. DOI: 10.4158/GL-2020-0524SUPPL. View

13.

Ross A, Manson J, Abrams S, Aloia J, Brannon P, Clinton S . The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2010; 96(1):53-8. PMC: 3046611. DOI: 10.1210/jc.2010-2704. View

14.

Bazarbashi N, Kapadia S, Nicholls S, Carlo J, Gad M, Kaur M . Oral Calcium Supplements Associate With Serial Coronary Calcification: Insights From Intravascular Ultrasound. JACC Cardiovasc Imaging. 2020; 14(1):259-268. DOI: 10.1016/j.jcmg.2020.06.030. View

15.

Heravi A, Michos E . Vitamin D and Calcium Supplements: Helpful, Harmful, or Neutral for Cardiovascular Risk?. Methodist Debakey Cardiovasc J. 2019; 15(3):207-213. PMC: 6822648. DOI: 10.14797/mdcj-15-3-207. View

16.

Melamed M, Michos E, Post W, Astor B . 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med. 2008; 168(15):1629-37. PMC: 2677029. DOI: 10.1001/archinte.168.15.1629. View

17.

Lutsey P, Michos E, Misialek J, Pankow J, Loehr L, Selvin E . Race and Vitamin D Binding Protein Gene Polymorphisms Modify the Association of 25-Hydroxyvitamin D and Incident Heart Failure: The ARIC (Atherosclerosis Risk in Communities) Study. JACC Heart Fail. 2015; 3(5):347-356. PMC: 4426050. DOI: 10.1016/j.jchf.2014.11.013. View

18.

Yang C, Shi X, Xia H, Yang X, Liu H, Pan D . The Evidence and Controversy Between Dietary Calcium Intake and Calcium Supplementation and the Risk of Cardiovascular Disease: A Systematic Review and Meta-Analysis of Cohort Studies and Randomized Controlled Trials. J Am Coll Nutr. 2019; 39(4):352-370. DOI: 10.1080/07315724.2019.1649219. View

19.

Melamed M, Muntner P, Michos E, Uribarri J, Weber C, Sharma J . Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease: results from NHANES 2001 to 2004. Arterioscler Thromb Vasc Biol. 2008; 28(6):1179-85. PMC: 2705139. DOI: 10.1161/ATVBAHA.108.165886. View

20.

Xiao Q, Murphy R, Houston D, Harris T, Chow W, Park Y . Dietary and supplemental calcium intake and cardiovascular disease mortality: the National Institutes of Health-AARP diet and health study. JAMA Intern Med. 2013; 173(8):639-46. PMC: 3756477. DOI: 10.1001/jamainternmed.2013.3283. View